Clinical Trial Update: Paediatric Safety Study in Cat-PAD [Phase 2]

View source ↗

Summary

A Phase 2 pediatric safety study of Cat-PAD for rhinoconjunctivitis has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinoconjunctivitis

Drugs mentioned

• Cat-PAD

Snippet

Sponsor: Circassia Limited | Conditions: Rhinoconjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2018-04-17